Kezar Life Sciences, Inc.
8.45%
616,502
1645666
49372L100
Dec 2, 2024
Jan 16, 2025, 06:33 PM
Reporting Persons (7)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Equal Talent Investments Limited | CO | 8.45% | 616,502 | 616,502 | 0 |
| Suk Ying Pauli Ng | Individual | 8.45% | 616,502 | 616,502 | 0 |
| Jill Marie Franklin | Individual | 0.00% | 0 | 0 | 0 |
| Morningside Venture Investments Limited | CO | 0.00% | 0 | 0 | 0 |
| Cheung Ka Ho | Individual | 0.00% | 0 | 0 | 0 |
| Peter Stuart Allenby Edwards | Individual | 0.00% | 0 | 0 | 0 |
| Frances Anne Elizabeth Richard | Individual | 0.00% | 0 | 0 | 0 |
Disclosure Items (4)
Common Stock, par value $0.001 per share
Kezar Life Sciences, Inc.
4000 Shoreline Court, South San Francisco, CA, 94080
Item 3 is hereby supplemented as follows: Between December 2, 2024 and December 3, 2024, Morningside Venture Investments Limited ("MVIL") sold an aggregate of 194,800 shares of Common Stock (See Item 5(c) below). On December 3, 2024, Equal Talent Investments Limited ("ETIL") sold an aggregate of 8,952 shares of Common Stock (See Item 5(c)below).
The Information contained on the cover pages is incorporated by reference to this Item 5.
The Information contained on the cover pages is incorporated by reference to this Item 5. The aggregate percentage of Common Stock reported beneficially owned by each person named herein is determined in accordance with SEC rules and is based upon 7,296,222 shares of Common Stock outstanding as of November 8, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on November 12, 2024, giving effect to the Reverse Stock Split. The applicable SEC rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities.
MVIL sold 3,752 shares of Common Stock at $7.55 per share on December 2, 2024 in an Open Market Sale. MVIL subsequently sold 191,048 shares of Common Stock at $7.03 per share on December 3, 2024 in an Open Market Sale. ETIL sold 8,592 shares of Common Stock at $7.03 per share on December 3, 2024 in an Open Market Sale.
N/A
N/A
99.1 Joint Filing Agreement 99.2 Power of Attorney dated as of March 2, 2023 for Frances Anne Elizabeth Richard 99.3 Power of Attorney dated as of March 2, 2023 for Jill Marie Franklin 99.4 Power of Attorney dated as of March 2, 2023 for Peter Stuart Allenby Edwards 99.5 Power of Attorney dated as of March 2, 2023 for Cheung Ka Ho 99.6 Power of Attorney dated as of March 2, 2023, for Suk Ying Pauli Ng